Bio Protocol: Mandatory vesting ends fully liquid insider allocations - 01 Oct 2026
Bio Protocol will introduce mandatory vesting on 1 October 2026 for all team, investor and advisor allocations in future launchpad sales. The policy ends fully liquid allocations for these groups and applies to sales on the platform going forward.The change follows the NeuroLabs advisor sell-off and addresses the immediate availability of insider tokens for sale. Insider recipients will no longer receive their entire allocations in immediately tradable form. Making vesting mandatory across future launches strengthens buyer protection as a platform policy rather than a condition set for individual sales. That protection is relevant to participation in future launches and the associated demand for BIO.Update on NeuroLabs Ignition SaleWe want to clarify what happened during the launch and what we’re changing going forward.1. Based on past launches, we intentionally didn’t communicate a specific finalization time to allow a buffer for the launch to finalize and for us to…